Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CAPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC257396 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TRAK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GIPC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100128653 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NXF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930075 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBX22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
H2AFY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RC3H2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEACAM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EQTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130872 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIDO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TATDN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMP17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on